BIOA — Bioiasis AD Balance Sheet
0.000.00%
HealthcareMicro Cap
Annual balance sheet for Bioiasis AD, fiscal year end - December 31st, BGN millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0.662 | 0.547 | 0.583 | 0.062 | 0.065 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.033 | 0.03 | 0.025 | 5.12 | 8.5 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 0.695 | 0.579 | 0.608 | 6.31 | 11.6 |
| Net Property, Plant And Equipment | — | — | — | — | 0 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 0.695 | 0.581 | 0.608 | 15.3 | 20.8 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.058 | 0.022 | 0.036 | 5.48 | 10.6 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Liabilities | 0.058 | 0.022 | 0.042 | 15.2 | 20.4 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Total Equity | 0.637 | 0.559 | 0.566 | 0.109 | 0.481 |
| Total Liabilities & Shareholders' Equity | 0.695 | 0.581 | 0.608 | 15.3 | 20.8 |
| Total Common Shares Outstanding |